RIVERSIDE, CA--(Marketwire - February 13, 2013) - Ingen Technologies, Inc. (PINKSHEETS: IGNT), an emerging medical device manufacturer with patented proprietary medical technology for the growing $55 Billion US home healthcare industry, has entered into an agreement with Tom Childers and Jim Shields, both Managing Members with WTP Holdings International, LLC.
As previously announced, the Company has been looking for the right person or company to represent Ingen's products, Oxyview and Smart Nasal Cannula with Oxyview, to various government markets such as the VA and Department of Defense. Since entering into this agreement with WTP, the Company anticipates selling up to $640k of product through the "Set Aside, Federal Supply Schedule Contract" it received in April of 2011.
After meeting and speaking with a number of representatives from the Veterans Administration, Childers has reported extremely positive feedback and is attending a follow up meeting with a purchasing member of the VA on Thursday, February 14th and expects to receive a Purchase Order soon thereafter.
"Mr. Childers has surpassed our expectations as the company has introduced our products to a number of non-government run Home Oxygen and related Oxygen Equipment companies in Atlanta and other areas within the southern and eastern United States, with additional market areas all across the U.S. soon to be contacted. This should give our product a wider range of exposure and eventually should lead to increased sales," stated Gary B Tilden, Chairman of Ingen Technologies.
VISIT OUR WEBSITE AT: www.ingen-tech.com or FACT SHEET AT: http://ingen-tech.com/files/documents/ignt-1112.pdf
ANALYST RESEARCH REPORT: http://www.otcmarkets.com/financialReportViewer?symbol=IGNT&id=95782
Safe Harbor for Forward-Looking Statements: This news release includes forward-looking statements. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.